-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

704. Cellular Immunotherapies: Early Phase Clinical Trials and Toxicities: Poster II

Symposia: Cellular Immunotherapies: Early Phase Clinical Trials and Toxicities Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 8, 2024: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Ehsan Malek, MD1, Kimberly Crasti, PA2*, Grant Schofield, MD3*, Shernan G. Holtan, MD2, Megan M Herr, PhD4, Marco Davila, MD, PhD3, You-Wen Qian, MD5*, Brian Betts, MD6, Mackenzie Lieberman, PhD2*, Jason Tong, PhD2*, Colin Chavel, PhD5*, Kelvin P. Lee, MD7 and Scott Olejniczak, PhD8*

1Roswell Park Comprehensive Cancer Center, Shaker Hts, OH
2Roswell Park Cancer Center, Buffalo
3Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY
4Roswell Park Comprehensive Cancer Center, Buffalo, NY
5Roswell Park Cancer Center, Buffalo, NY
6Division of Hematology, Oncology, and Transplantation, Department of Medicine, Roswell Park, Buffalo, NY
7Melvin and Bren Simon Comprehensive Cancer Center, INDIANA UNIVERSITY, INDIANAPOLIS, IN
8Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, NY

Evandro Bezerra, MD1, George Durisek III, MBA2*, Qiuhong Zhao, MS1*, Nathan Denlinger, DO, MS1, Timothy Voorhees, MD, MSc1, Gabriela Sanchez-Petitto, MD1, Francesca Cottini, MD3, Audrey M. Sigmund, MD1, Yazeed Sawalha, MD1, Polina Shindiapina, MD, PhD1*, Sarah A. Wall, MD, MPH1, David A. Bond, MD, BS1, Hannah Choe, MD1, Jonathan E. Brammer1, Beth Christian, MD1, Sam Penza, MD1, Samantha M. Jaglowski, MD, MPH4, Kami J. Maddocks, MD1, Spero Cataland, MD1, Marcos de Lima1* and Sumithira Vasu, MD, MBBS1

1Division of Hematology, The Ohio State University, Columbus, OH
2College of Medicine, The Ohio State University, Columbus, OH
3The Ohio State University, Columbus, OH
4Medical College of Wisconsin, Milwaukee, WI

Qian Cheng1*, JingWen Tan2*, Rui Liu1*, Liqing Kang2*, Hongjia Zhu2*, Yi Zhang1*, Erhua Wang1*, Ying Li, MD1*, Jian Zhang1*, Han Xiao3*, Rong He, MD4, Xiaoyan Lou2*, Nan Xu2*, Wei Wang2*, Zhou Yu2*, Minghao Li2*, Hongfei Gu5*, Lei Yu2* and Xin Li1*

1Department of Hematology, Third Xiangya Hospital of Central South University, Changsha, China
2Shanghai Unicar-Therapy Bio-Medicine Technology Co.,Ltd, Shanghai, China
3Department of Gastrointestinal Surgery, The Third Xiangya Hospital of Central South University, Changsha, China
4Division of Hematopathology, Mayo Clinic, Rochester, MN
5Hongmian Cancers and Rare Disorders Charity Foundation of Guangzhou, Guangzhou, China

Nirav N. Shah, MD1,2, Aniko Szabo, PhD3*, Tyce Kearl, MD4*, Dina Schneider, PhD5, Walter Longo, MD6*, Bryon D. Johnson, PhD7*, Peiman Hematti, MD8, Mehdi Hamadani, MD1 and Timothy S. Fenske, MD1

1Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI
2Medical College of Wisconsin, Brookfield, WI
3Medical College of Wisconsin, Milwaukee, WI
4Division of Hematology/Oncology, Medical College of Wisconsin, MIlwaukee, WI
5Lentigen Technology, Inc, A Miltenyi Biotec Company, Gaithersburg, MD
6Medical College of Wisconsin, Division of Hematology/Oncology, Milwaukee, WI
7Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee
8Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI

Mayur S. Narkhede, MD1, Antonio Di Stasi, MD2*, Lauren Kelly Shea, MD, MS1, Susan Bal, MD3, Gayathri Ravi, MD3, Gaurav Goyal, MD4, Pamela Hardwick5*, Smith Giri, MD, MHS3*, Donna Salzman, MD6, Ravi Bhatia, MD7, Luciano J. Costa, MD, PhD8 and Amitkumar Mehta, MD6*

1O’Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL
2O’Neal Comprehensive Cancer Center, University of Alabama At Birmingham, Birmingham, AL
3Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL
4Division of Hematology and Medical Oncology, University of Alabama at Birmingham, Birmingham, AL
5University of Alabama At Birmingham, Birmingham, AL
6University of Alabama at Birmingham, Birmingham, AL
7Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL
8Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Vestavia, AL

Armin Ghobadi, MD1, Ibrahim Aldoss, MD2, Shannon L. Maude, MD3, Deepa Bhojwani, MD4, Rawan Faramand, MD5, Ashish Bajel, MBBS, FRACP, FRCPA6, Friso G. J. Calkoen, MD7, Alan S. Wayne, MD8, Bhagirathbhai R. Dholaria, MBBS9, Ryan J Mattison, MD10, Anita W. Rijneveld, MD, PhD11, Christian Michel Zwaan, MD12, André Baruchel, MD, PhD13, Nicolas Boissel, MD, PhD14, Michael P. Rettig, PhD15, Maria del Rosario, BA CCRP16*, Stephen Moran17*, Alexander Hamil, PhD18*, Ouiam Bakkacha, MD19*, Deborah Masters, RN MS16*, Justo L. Gonzalez, MD16*, Michael Munroe, BS PhD16*, Laura Simpson, PhD20*, Preeta Dasgupta, PhD21*, Tony Wu, PhD22*, John Muth, MSc17*, Haley Irons23*, Brett Ramsey, MBA19*, Eileen McNulty, MS24*, Matthew L. Cooper, PhD25, Jan K Davidson-Moncada, MD, PhD, MSc26 and John F. DiPersio, MD, PhD27

1Division of Oncology, Washington University School of Medicine, St. Louis, MO
2Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
3The Children's Hospital of Philadelphia, Philadelphia, PA
4Hematology/Oncology, Children's Hospital of Los Angeles, Los Angeles, CA
5Department of Blood and Marrow Transplantation and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
6Clinical Haematology, Royal Melbourne Hospital, Parkville, Australia
7Prinses Maxima Centrum Voor Kinderoncologie, Utrecht, Netherlands
8Children's Hospital of Los Angeles, Los Angeles, CA
9Vanderbilt University Medical Center, Nashville, TN
10Carbone Cancer Center, University of Wisconsin-Madison, Madison, WI
11Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, Netherlands
12Department of Pediatric Oncology, Erasmus MC/Sophia Children's Hospital, Rotterdam, Netherlands
13Institut Universitaire d'Hématologie, EA-3518, University Hospital Saint-Louis, Assistance Publique des Hôpitaux de Paris (APHP), Paris, France
14Hematology Adolescents and Young Adult Unit, Saint-Louis Hospital, APHP, Paris, France, Paris Cedex 10, Paris, France
15Washington Univ. School of Med., Saint Louis, MO
16Wugen, St Louis
17Wugen, St. Louis, MO
18Wugen, San Diego
19Wugen, Saint Louis, MO
20Wugen, Tarrytown, NY
21Wugen, San Diego, CA
22Wugen, St. Louis
23Wugen, Surprise, AZ
24Wugen, St Louis, MO
25Wugen Inc., Saint Louis, MO
26Wugen, Washington, DC
27Division of Oncology, Washington University School of Medicine, Saint Louis, MO

Juan Du, MD, PhD1, Lina Jin2*, Sinan Gu1*, Jing Lu1*, Haiyan He2*, Qianqi Ruan1*, Wanting Qiang2*, Xiaoqiang Fan2*, Jin Liu2*, Xingxing Meng3*, Nishanthan Rajakumaraswamy3*, Deng Chen3* and Zonghai Li3*

1Department of Hematology, Myeloma & Lymphoma Center, Shanghai Changzheng Hospital, Naval Medical University, Shanghai, China
2Department of Hematology, Myeloma & Lymphoma Center, Shanghai Changzheng Hospital, Shanghai, China
3CARsgen Therapeutics Co. Ltd., Shanghai, China

Valentin Ortiz-Maldonado, MD, PhD, MSc1, Nuria Martinez-Cibrian, MD2*, Leticia Alserawan1*, Sergi Betriu1*, Ana Triguero1*, Sandra Blum3*, Margaux Faes4*, Marte C. Liefaard5*, Margot J. Pont5*, Maike Spoon5*, Kirsten Van Hoorde6*, Anna D. D. van Muyden5, Julio Delgado, MD, PhD1* and Natalia Tovar1*

1Hospital Clínic de Barcelona, Barcelona, Spain
2Hematology Department, Hospital Clínic Barcelona, Barcelona, Spain, Barcelona, Spain
3Galapagos GmbH, Basel, Switzerland
4Galapagos NV, Mechelen, Belgium
5Galapagos BV, Oegstgeest, Netherlands
6Open Analytics NV, Antwerp, Belgium

Maria Lia Palomba, MD1, Paolo F. Caimi, MD2, Matthew Mei, MD3, Francisco Hernandez-Ilizaliturri, MD4, Geoffrey Shouse, PhD, DO3, Allison M. Winter, MD2, Greg Yedinak5*, David Mou5*, Nestor Huang5*, Anna Moua, BS5*, Martin Oft, MD5*, Paul-Joseph Aspuria, PhD5*, Anita Mehta-Damani, PhD5*, Naiyer Rizvi, MD5*, Sherry Unabia5*, Peg Taylor, BS5*, Jeffrey McLeroy5* and Matthew J Cortese, MD, MPH4

1Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
2Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
3City of Hope National Medical Center, Duarte, CA
4Department of Medicine (Lymphoma Section), Roswell Park Comprehensive Cancer Center, Buffalo, NY
5Synthekine Inc, Menlo Park, CA

Caroline Diorio, MD1, Regina M. Myers, MD1, Yimei Li, PhD2*, Amanda M. Dinofia, MD, MSCE1*, Hongyan Liu3*, Allison Barz Leahy, MD, MSc1, Haley Newman, MD1, Jillian Dolan4*, Zachary Martinez1*, Amira Elhachimi, BA1*, Cassidy Mullen, BSc4*, Alexander Lai Li4*, John Kim4*, David T. Teachey, MD3, Shannon L. Maude, MD5, Jennifer McGuire4* and Stephan A. Grupp, MD, PhD6

1Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA
2Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA
3Children's Hospital of Philadelphia, Philadelphia, PA
4Children's Hospital of Philadelphia, Philadelphia
5The Children's Hospital of Philadelphia, Philadelphia, PA
6Children’s Hospital of Philadelphia and Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA

Nathan P Jeffreys, MBBS1*, Roisin Borrill, MBBS, BSc1*, Claire Horgan, MD PhD2*, Omima Abdalla Mustafa, MD1*, Ramya Nataraj, MBBS1*, Simon J Stanworth, MA, FRCP (Paeds, UK), DPhil, FRCPath3*, Suzy M Morton, MBBCh4*, Kay Poulton, PhD, FRCPath5*, Srividhya Senthil, MBBS1* and Robert F. Wynn, MRCP, MD, FRCPath1*

1Blood and Marrow Transplant Unit, Royal Manchester Children's Hospital, Manchester, United Kingdom
2Royal Manchester Children's Hospital, Blood and Marrow Transplant Unit, Manchester University NHS Foundation Trust, Manchester, United Kingdom
3NHS Blood and Transplant, Oxford, United Kingdom
4NHS Blood and Transplant, Birmingham, United Kingdom
5Manchester Royal Infirmary, Manchester, United Kingdom

Guillaume Dachy, MD, PhD1*, Jarl E Mooyaart2*, Ibrahim Yakoub-Agha, MD, PhD3*, Michael Daskalakis4*, Ludovic Gabellier, MD, PhD5*, Victoria Potter6*, Christof Scheid, MD7, Peter Dreger, MD, PhD8, Didier Blaise, MD, PhD9, Anne Huynh, MD10*, Caroline Besley, MBChB, MRCP, FRCPath, PhD11*, Matthew Collin, MD, PhD12, Peter Vandenberghe, MD, PhD13, Lucia Lopez Corral, MD14*, Gerald Wulf15*, Francis A. Ayuk, M.D.16*, Carlos Solano, MD, PhD17, Edouard Forcade, MD, PhD18*, Jorinde D. Hoogenboom19*, Jurgen Kuball, MD20, Annalisa Ruggeri, MD, PhD21* and Florent Malard, M.D., Ph.D.22*

1Hematology department, Cliniques Universitaires Saint-Luc, Wezembeek-Oppem, Belgium
2EBMT Data Office Leiden, Leiden, Netherlands
3CHU de Lille, Univ Lille, INSERM U1286, Infinite, 59000, LILLE, France
4University Hospital, University of Bern, Bern, Switzerland
5Hematology Departement, CHU Montpellier University Hospital, UMR-CNRS 5535, Montpellier, France
6King's College Hospital, London, United Kingdom
7Department of Internal Medicine I, University Hospital Cologne, Cologne, Germany, Cologne, Germany
8Department of Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Baden-Wuerttemberg, Germany
9Program of Transplant and cellular immunotherapy, Department of Hematology, Institut Paoli Calmettes, Marseille, France
10Hematology Department, Institut Universitaire du Cancer Toulouse - Oncopole, Toulouse, France
11Department of Haematology, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, United Kingdom
12Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, United Kingdom
13Department of Hematology, Department of Human Genetics, University Hospitals Leuven, KU Leuven, Leuven, Belgium
14Hospital Universitario de Salamanca, IBSAL., Salamanca, Spain
15Department of Hematology and Medical Oncology, University Hospital Goettingen, Goettingen, Germany
16University Hospital Hamburg, Hamburg, Germany
17Department of Hematology, Hospital Clínico Universitario, University of Valencia, Valencia, Spain
18CHU Bordeaux, Pessac, France
19EBMT Leiden Study Unit, Leiden, Netherlands
20Department of Hematology, University Medical Centre, Utrecht, Netherlands
21Hematology and Bone Marrow Transplant Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy
22Sorbonne Université, Hôpital Saint-Antoine, AP-HP, Service d'Hématologie Clinique et Thérapie Cellulaire,Centre de Recherche Saint-Antoine UMRs938, Paris, France

Raynier Devillier, MD, PhD1*, Anne Huynh, MD2*, Patrice Chevallier, MD, PhD3, Simona Piemontese4*, Regis Peffault de Latour, MD, PhD5*, Patrizia Chiusolo, MD6*, Aurelie Bauquet7*, Rahim Fandi, MD8*, Sebastien Oster7*, Laura Simons9*, Isabelle Andre, PhD10*, Marina Cavazzana, MD, PhD11 and Fabio Ciceri, MD12*

1Hematology and Transplantation, Institut Paoli-Calmettes, Aix Marseille University, Marseille, France
2Department of Hematology and Bone marrow Transplantation, CHU Toulouse - Institut Universitaire du Cancer Toulouse – Oncopole, Toulouse, France
3CHU Hôtel-Dieu, Nantes, France
4Hematology and Bone Marrow Transplantation, IRCCS San Raffaele Scientific Institute, Milan, Italy
5Hematology and Transplant Unit, Saint Louis Hospital, APHP, Paris, France
6Department of Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Policlinico Gemelli, ROMA, ITA
7Smart Immune, Paris, France
8Smart Immune, Paris, FRA
9Internal Medicine V, Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany
10Paris Cité University, Imagine Institute, INSERM UMR 1163, Paris, France
11Inserm Assistance Publique Hôpitaux de Paris, Imagine Institute, and 4Hospital Necker, University Paris Descartes, Paris, France
12Hematology and Bone Marrow Transplantation Unit, I.R.C.C.S. San Raffaele Scientific Institute, Milan, Italy

Jae H. Park, MD1, Elias Jabbour, MD2, Paul Shaughnessy, MD3, Aaron C. Logan, MD, PhD4, Karamjeet S Sandhu, MD5, Mehrdad Abedi, MD6*, Bijal D Shah, MD7, Michael R Bishop, MD8, Daniel J. DeAngelo, MD, PhD9, Pierre Lao-Sirieix, PhD10*, Wolfram Brugger, MD11*, Martin A Pule, MD10*, Justin Shang, PhD12* and Claire Roddie, MD13*

1Memorial Sloan Kettering Cancer Center, New York, NY
2University of Texas MD Anderson Cancer Center, Houston, TX
3Sarah Cannon Transplant and Cellular Therapy Program, Methodist Hospital, San Antonio, TX
4Hematology, Blood and Marrow Transplantation, and Cellular Therapy Program, University of California at San Francisco, San Francisco, CA
5City of Hope National Medical Center, Duarte, CA
6University of California Davis, Davis, CA
7Moffitt Cancer Center, Tampa, FL
8The David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL
9Dana-Farber Cancer Institute, Boston, MA
10Autolus Therapeutics, London, United Kingdom
11Autolus Therapeutics, Munich, Germany
12Autolus Therapeutics, Rockville, MD
13University College London Cancer Institute, London, United Kingdom

Na Hyun Kim, MBBS1, Fatima Khamissi2*, Kathleen Bone, PhD3*, Nathan Kopp, PhD3*, Walter Longo, MD4*, Bryon D. Johnson, PhD5*, Tyce Kearl, MD6*, Peiman Hematti, MD7, Mehdi Hamadani, MD8, Timothy S. Fenske, MD9 and Nirav N. Shah, MD10

1Medical College of Wisconsin, Milwaukee, WI
2Medical College of Wisconsin, Milaukee
3Medical College of Wisconsin, Milwaukee
4Medical College of Wisconsin, Division of Hematology/Oncology, Milwaukee, WI
5Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee
6Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI
7Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
8Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
9Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI
10Medical College of Wisconsin, Brookfield, WI

Mary McKiever, PharmD1*, Maribel Pereiras, PharmD, BCOP2*, Geeny Lee, PharmD, BCOP2* and Michele L. Donato, MD3

1Department of Pharmacy, Hackensack University Medical Center, Brielle, NJ
2Department of Pharmacy, Hackensack University Medical Center, Hackensack, NJ
3Stem Cell Transplantation and Cellular Therapy Program, John Theurer Cancer Center, Hackensack Meridian Health, Hackensack, NJ

Shannon L. Maude, MD1, Deepa Bhojwani, MD2, Alan S. Wayne, MD3, Friso G. J. Calkoen, MD4, André Baruchel, MD, PhD5, Christian Michel Zwaan, MD6, Michael P. Rettig, PhD7, Ouiam Bakkacha, MD8*, Justo L. Gonzalez, MD9*, Deborah Masters, RN MS9*, Maria del Rosario, BA CCRP9*, Laura Simpson, PhD10*, Preeta Dasgupta, PhD11*, Tony Wu, PhD12*, Stephen Moran13*, Michael Munroe, BS PhD9*, Haley Irons14*, Eileen McNulty, MS15*, Matthew L. Cooper, PhD16, Alexander Hamil, PhD17*, John Muth, MSc13*, Brett Ramsey, MBA8*, Jan K Davidson-Moncada, MD, PhD, MSc18 and John F. DiPersio, MD, PhD19

1Division of Oncology, Center for Childhood Cancer Research and Cancer Immunotherapy Program, Children's Hospital of Philadelphia, Philadelphia, PA
2Hematology/Oncology, Children's Hospital of Los Angeles, Los Angeles, CA
3Children's Hospital of Los Angeles, Los Angeles, CA
4Prinses Maxima Centrum Voor Kinderoncologie, Utrecht, Netherlands
5Institut Universitaire d'Hématologie, EA-3518, University Hospital Saint-Louis, Assistance Publique des Hôpitaux de Paris (APHP), Paris, France
6Department of Pediatric Oncology, Erasmus MC/Sophia Children's Hospital, Rotterdam, Netherlands
7Washington Univ. School of Med., Saint Louis, MO
8Wugen, Saint Louis, MO
9Wugen, St Louis
10Wugen, Tarrytown, NY
11Wugen, San Diego, CA
12Wugen, St. Louis
13Wugen, St. Louis, MO
14Wugen, Surprise, AZ
15Wugen, St Louis, MO
16Wugen Inc., Saint Louis, MO
17Wugen, San Diego
18Wugen, Washington, DC
19Division of Oncology, Washington University School of Medicine, Saint Louis, MO

Jingwen Tang, MS1*, Liping Dou, MD2 and Daihong Liu, MD2*

1Medical School of Chinese PLA, Beijing, China
2Department of Hematology, The Fifth Medical Center of Chinese PLA General Hospital, Beijing, China

Carmen Mestre Durán, MSc1*, Odelaisy Leon Triana2,3*, Lidia Pertiñez, MLT2*, David Bueno, MD, PhD4*, Luisa Sisinni, MD, PhD4*, Isabel Badell5*, Marta González Vicent, MD6*, Cristina Belendez, MD7*, Pilar Palomo Moraleda, MD8*, Yasmina Mozo, MD4*, Laura Clares Villa, MSc2*, Carlos Echecopar, MD4*, Karima Al-Akioui Sanz, MSc2*, Victor Galan-Gomez9*, Pilar Guerra Garcia, MD4,10*, Cristina Aguirre, PhD2*, Carlos Solano, MD, PhD11 and Antonio Perez Martinez, MD2,12,13*

1CIBERER-ISCIII, IdiPAZ-CNIO Pediatric Onco-Hematology Clinical Research Unit, Madrid, Spain., Madrid, AL, Spain
2CIBERER-ISCIII, IdiPAZ-CNIO Pediatric Onco-Hematology Clinical Research Unit, Madrid, Spain
3Castilla-La Mancha University, Ciudad Real, Spain
4Pediatric Hemato-Oncology Department, La Paz University Hospital, Madrid, Spain
5Pediatric Hemato-Oncology, Hospital Santa Creu I Sant Pau, Barcelona, Spain, Barcelona, Spain
6Pediatric Hemato-Oncology, Niño Jesús University Children's Hospital, Madrid, Spain
7Pediatric Hemato-Oncology, Hospital Gregorio Marañón, IiSGregorio Marañón, CIBERER-ISCIII, ERN-EuroBloodNet, Faculty of Medicine, Universidad Complutense, Madrid, Spain
8Pediatric Hematology Unit, Hematology Department, Central University Hospital of Asturias, Oviedo, Spain., Òviedo, Spain
9Pediatric Hemato-Oncology Department, La Paz University Hospital, MADRID, Spain
10Translational Research in Pediatric Oncology, Hematopoietic Transplantation and Cell Therapy, Hospital La Paz Institute for Health Research-IdiPAZ, Madrid, Spain
11Hematology Department, Hematology Department, Hospital Clínico Universitario-INCLIVA, Valencia, Spain
12Pediatric Hematology-Oncology Department, La Paz University Hospital, Madrid, ESP
13Universidad Autónoma, Pediatric Department at Faculty of Medicine, Madrid, Spain

Michael P. Chu, MD1, Zack Breckenridge, BSc2*, Deanna Hockley, PhD3*, Mona Shafey, MD4, Sunil J. Desai, MBBS, FRCPC5, Victor A. Lewis, MD6*, Peng Wang, MD, PhD7*, Vladimir Sapon-Cousineau, MD8*, Charles Yin, MD, PhD9, Carina Debes-Marun3* and Irwindeep Sandhu, MD10

1Department of Medical Oncology, Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada
2University of Calgary, Calgary, Canada
3University of Alberta, Edmonton, Canada
4Tom Baker Cancer Centre and University of Calgary, Calgary, Canada
5Stollery Childrens Hospital, Edmonton, AB, CAN
6University of Calgary, Calgary, AB, Canada
7Department of Medicine, University of Alberta, Edmonton, AB, Canada
8Cross Cancer Institute, University of Alberta, Edmonton, Canada
9University of Alberta, Edmonton, AB, Canada
10Cross Cancer Institute, Edmonton, AB, Canada

Min Yu1,2*, Fancong Kong3*, Yulan Zhou3*, Tongcun Zhang4*, Fei Li5 and Ling Qi5*

1Department of Hematology,Jiangxi Clinical Research Center for Hematologic Disease,Jiangxi Provincial Key Laboratory of Hematological Diseases, The First Affiliated Hospital, Jiangxi Medical College, Nanchang, China
2First Affiliated Hospital of Nanchang University, Nanchang, China
3Center of Hematology, The First Affiliated Hospital of Nanchang University, Nanchang, China
4Institute of Biology and Medicine, College of Life and Health Sciences, Wuhan University of Science and Technology, Wuhan, China
5Department of Hematology, Jiangxi Clinical Research Center for Hematologic Disease, Jiangxi Provincial Key Laboratory of Hematological Diseases, The First Affiliated Hospital, Jiangxi Medical College, Nanchang, China;, Nanchang, China

Yibing Zhang1*, Jing PAN, MD, PhD2, Fan Wu3*, Zhuojun Ling3* and Kai Wang3*

1State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
2Dept of Hemato-Oncology and immunotherapy, Beijing Gobroad Hospital, Beijing, China
3Dept of Hemato-Oncology and immunotherapy, Beijing GoBroad Hospital, Beijing, China

Yuehui Lin1*, Defeng Zhao2*, Biping Deng, BS, MD3*, Dan Liu4*, Hong Yan, Bachelor of Medicine5*, Biyi Li, Master of Medical Science5*, Yu Xia6*, Ruyue Zheng, Master of Medical Science5*, Tong Wu, MD7,8 and Chunrong Tong4*

1Department of Haematology, Beijing Gobroad Boren Hospital, Beijing, China
2Beijing Gobroad Boren Hospital, Beijing,China, AL, China
3Department of Cytology Laboratory, Beijing Gobroad Boren Hospital, Beijing, China
4Beijing Gobroad Boren Hospital, Beijing, China
5Beijing Boren Hospital, Beijing, China
6Beijing Gobroad Boren Hospital, Department of Cytology Laboratory, China, Beijing, China
7Department of Bone Marrow Transplantation, Beijing GoBroad Boren Hospital, Beijing, China
8Beijing Boren Hospital, Langfang, Hebei, CHN

Daniel K Reef, MD1, Catherine Joyce Arago Cheng, BS1*, Caroline Babinec1*, Kelly Hoye1*, John West, PhD1*, J. Kaitlin Morrison, PhD1*, Faith Brianne Buchanan, PA-C1*, Ashley Zanter, ANP-BC, AOCNP1*, Angela Denise Spruill, ANP1*, Kimberly A. Kasow, DO1*, Anastasia Ivanova, PhD1,2*, Edith Bowers, MD, PhD1,3*, Jonathan Serody, MD1,4, Barbara Savoldo, MD, PhD1,4,5*, Gianpietro Dotti, MD1,4*, Natalie Grover, MD6 and Anne W Beaven, MD1

1Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC
2Department of Biostatistics, University of North Carolina, Chapel Hill, NC
3Department of Dermatology, University of North Carolina-Chapel Hill, Chapel Hill, NC
4Department of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill, NC
5Department of Pediatrics, University of North Carolina School of Medicine, Chapel Hill, NC
6University of North Carolina, Chapel Hill, NC

Lichao Liu1*, Ruihao Huang, PhD student2*, Yongxian Hu3*, Sanfang Tu4*, Na Wang5*, Hai Yi, MD6*, Qiuying Gao7*, Jian Zhou, MD, PhD8*, Xiaoqi Wang, MD2*, Cheng Zhang, MD, PhD1* and Xi Zhang, PhD9

1Xinqiao Hospital, Army Medical University, Chongqing, China
2Army medical University affiliated Xinqiao Hospital, Chongqing, China
3Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
4Department of Hematology, Zhujiang Hospital of Southern Medical University, Guangzhou, China
5Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, CHN
6Department of Hematology, The General Hospital of Western Theater Command, Chengdu, China
7Department of Hematology, Shaanxi Provincial People's Hospital, Xi'an, China
8Department of Hematology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China
9Medical Center of Hematology, Xinqiao Hospital of Army Medical University, State Key Laboratory of Trauma and Chemical Poisoning, Chongqing Key Laboratory of Hematology and Microenvironment, Chongqing, China

Madhav R Seshadri, MD1, Sasha Gupta, MD2*, Robin Lincoln2*, Naomi Okinishi2*, Nancy Thomas2*, Jenai Wilmoth, RN3*, Stephen L Hauser, MD2* and Bruce A C Cree, MD2*

1University of California San Francisco, San Francisco, CA
2Department of Neurology, University of California, San Francisco, San Francisco, CA
3Division of Hematology and Oncology, University of California, San Francisco, San Francisco, CA

*signifies non-member of ASH